NTT Venture Capital (NTTVC) is a venture capital firm that focuses on investing in and supporting innovative technology companies. The firm leverages the strength, stability, and network of the global NTT ecosystem to provide its portfolio companies with strategic resources to accelerate their growth.

NTT Venture Capital

NTTVC is an independent venture capital firm formed in collaboration with NTT. We invest across sectors and partner as early as a founder’s first inspiration through the full expression of their vision. We act with conviction, move fast, and back innovative ideas.

Through our unique partnership-focused strategy and deep industry network, we unlock doors to relationships that help startups reach global scale. Our portfolio companies benefit from unfettered access to the voices that matter – industry experts, customers, entrepreneurs, business leaders, system integrators and service providers. This virtually unlimited data feed offers an incredible level of insight to help startups make better decisions, more quickly. 

NTTVC

NTTVC portfolio company nference was recently named to Newsweek's list of top 50 best healthcare data analytics companies in the US! Becker's Healthcare featured the list of the data analytics-focused digital health companies.

Check it out: https://lnkd.in/eg4Y_Daa

cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, Mike Koenig, John Halamka, M.D., M.S., Zachi Attia, Andy Danielsen, Mayo Clinic, Mayo Clinic Ventures

#digitalhealth #dataanalytics #healthcare #healthcaredata #newsweek #top50

Excited to see how Pramana is helping transform the digital pathology market and has digitized over 6.5 million glass slides and validated 15 billion images with near-perfect accuracy using Pramana’s in-line quality assurance algorithms. Congratulations and more to come! 

“Our strides in advancing digital pathology, in collaboration with Image Management System partners, have led to the creation of the largest DICOM dataset for digital pathology, paving the way for a future where proprietary image formats are no longer necessary and marking a new era in digital pathology.” – ​​Prasanth Perugupalli, Pramana Chief Product Officer.

Read more about how they are revolutionizing the landscape of pathology labs: https://lnkd.in/eH4FF5zx 

cc: Murali Aravamudan, Prasanth Perugupalli, Mike Koenig, Duke University School of Medicine, Mayo Clinic

#digitalpathology #pathology #AI #GenAI

We're thrilled to support Neysa Networks in their $20m seed funding. Welcome to the NTTVC portfolio! India's first GPU AI cloud and platform-as-a-service company will use the funding to accelerate #generativeAI adoption for enterprises. 

Neysa co-founder and CEO Sharad Sanghi helped fuel the growth of the internet and cloud in India. We are looking forward to working with you again, Sharad Sanghi and Anindya Das.

Read more in Entrepreneur India: https://lnkd.in/eBVPcQ55 

cc: Jishnu B., Avnish Bajaj, BV Jagadeesh, Abhijit Dubey, Charlie Li, NTT DATA, Inc., NTT Global Data Centers and Cloud Infrastructure, India, Vab Goel, Fay Hazaveh Costa 

#AI #generativeAI #enterpriseAI #genAI #funding #seedfunding

A big congratulations to Eko Health on receiving FDA clearance for its Low EF detection AI, developed in collaboration with Mayo Clinic. Low ejection fraction is a primary source of heart failure and can now be detected during routine physical examinations in just 15 seconds using an Eko stethoscope.

“The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with—the stethoscope—can help us prevent hospitalizations and adverse events. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.” - Mayo Clinic Cardiovascular Medicine Department Chair, Paul Friedman, M.D.
 
Read more in Fierce Biotech: https://lnkd.in/gV4Khbcr
 
cc: Connor Landgraf, Jason Bellet, Subbu Venkatraman, Mayo Clinic Ventures, John Halamka, M.D., M.S. 
#fdacleared #digitalhealth #stethoscope #ai #healthtech

Metric
Company Name	NTT Venture Capital
Symbol
MSH ID	COM:NTTVC
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	10
Website	nttvc.com
LinkedIn	nttventurecapital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	75
Web Traffic Growth	-0.97
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NTTVC

NTT Venture Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue